Emblaveo MDR Infections: Evaluating a New Solut...

By HEOR Staff Writer

November 18, 2025

Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avib...
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Advancing Kidney Transplant Transparency Through Patient Involvement
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
China Medical Research Challenges: Pushing Boundaries Amid Ethical and Qualit...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Aligning Medical Schemes with National Health Insurance South Africa
Obesity Health Economics: Forecasting Trends and Costs in the US